Limited coverage drugs – ropinirole

Last updated on October 7, 2022

Special Authority requests can now be submitted online. It's simple and quick!


Generic name		ropinirole
Strength		0.25 mg, 1 mg, 2 mg, 5 mg
Form		tablet

Special Authority criteria	Approval period
For the treatment of idiopathic Parkinson's disease, when: the patient is receiving treatment with levodopa and requires additional adjunctive therapy OR the patient cannot tolerate or has contraindications to levodopa	Indefinite

Special Authority criteria

Approval period

For the treatment of idiopathic Parkinson's disease, when:

the patient is receiving treatment with levodopa and requires additional adjunctive therapy
OR
the patient cannot tolerate or has contraindications to levodopa

Indefinite

Practitioner exemptions

None

Special notes

None

Special Authority requests

Log in to eForms
HLTH 5328 Special Authority request form (PDF, 523KB)

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics

Limited coverage drugs – ropinirole

Practitioner exemptions

Special notes

Special Authority requests